Together we will beat cancer

Harry Jenkins

Harry studied an integrated Master’s degree in biology at Durham University before joining Cancer Research UK in November 2018. He completed a Master’s in science communication at Imperial College London part-time alongside his work in communications teams across the charity. He worked in Cancer Research UK’s digital news team, writing news and analysis articles for their news site as well as information about their funded research for their website. He has since left Cancer Research UK.

Detecting multiple cancers with a ‘simple’ blood test: Where are we?

A blood test capable of catching any cancer at an early stage before any symptoms may sound like science fiction but just how close are researchers to making it a reality?

Read More

Health inequalities: “We have a moral duty to reduce them”

This entry is part 1 of 4 in the series Health inequalities

We talk to Professor Sir Michael Marmot, who’s been at the forefront of health inequality research for decades, to discuss what it is and how we can reduce it.

Read More

New breast and lung cancer treatments approved in Scotland

3 new cancer treatments have now been approved by the Scottish Medicines Consortium (SMC) for use on the NHS in Scotland, including 2 breast cancer treatments and 1 for lung cancer.

Read More

New lung cancer treatment combo approved on NHS in England

A new treatment for some people with a type of non small cell lung cancer (NSCLC) will now be routinely available on the NHS in England, following its approval by the National Institute of Health and Care Excellence (NICE).

Read More

Immunotherapy approved for some people with advanced melanoma in England

The National Institute for Health and Care Excellence has recommended the use of the immunotherapy drug pembrolizumab (Keytruda) for some adults in England with a type of advanced melanoma skin cancer.

Read More

6 of the biggest good news cancer stories of 2021

From promising new cancer drugs to trialling a cancer blood test, here are some of the top good news stories from 2021.

Read More

Over 600 people in England set to benefit from innovative lung cancer treatment

More than 600 people in England with a form of lung cancer could benefit from the innovative drug osimertinib (Tagrisso) after its approval by the National Institute for Health and Care Excellence.

Read More

Childhood cancer survivors at greater risk of ill health

People who survive cancer in childhood have a higher risk of ill health as they grow older, according to new research published in The Lancet Regional Health – Europe.

Read More

Three cancer drugs approved for NHS use in Scotland

Three new cancer drugs have been given the go-ahead by the Scottish Medicines Consortium (SMC) for routine use in Scotland, two for non small cell lung cancer and one for Hodgkin lymphoma, but a fourth has been rejected.

Read More

Unravelling the mystery of Barrett’s oesophagus

Barrett’s oesophagus affects around 1 in every 100 to 200 people in the UK, and, for a small number of people, can develop into oesophageal cancer. But the origins of the condition have remained a mystery for decades, until now.

Read More